CXCR4 and cancer: MDSCs accumulate in tumors in response to growth factors, and inflammatory mediators,65 that upregulate CXCR4 and its ligand CXCL12 in cancer‐associated MDSCs providing a rationale for targeting CXCR4 in OvCa therapy66 (Table 1).